Tango Therapeutics to go public via merger with Boxer Capital-backed SPAC

Tango Therapeutics, a biotech company, has agreed to go public via a merger with BCTG Acquisition Corp, a blank check company backed by Boxer Capital.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this